Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors. [electronic resource]
Producer: 20171218ISSN:- 1946-6242
- Allyl Compounds -- pharmacology
- Anemia, Diamond-Blackfan -- drug therapy
- Antigens, CD34 -- metabolism
- Autophagy -- drug effects
- Autophagy-Related Protein 5 -- metabolism
- Cell Differentiation -- drug effects
- Cellular Reprogramming
- Drug Discovery
- Erythroid Cells -- drug effects
- Erythropoiesis -- drug effects
- Genetic Complementation Test
- Globins -- metabolism
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cells -- drug effects
- Humans
- Induced Pluripotent Stem Cells -- drug effects
- Quinazolines -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.